Analyst firms · Citigroup · QDEL

Citigroup QDEL price target and rating history

QuidelOrtho Corporation (QDEL) · Health Care

Citigroup rates QuidelOrtho Corporation (QDEL) Neutral with a $33 price target, as of its latest action on Oct 7, 2025. It has published 5 rating actions on QDEL since September 2022, including 2 upgrades and 2 downgrades.

Current rating

Neutral

Price target

$33

Median target, all firms

Too few

Actions on QDEL

5

Citigroup price target on QDEL

Every Citigroup rating on QDEL

• Oct 7, 2025
  DowngradeCitigroup downgrades to Neutral from Buy, price target $33
• Dec 11, 2024
  UpgradeCitigroup upgrades to Buy from Neutral, price target $44 to $50
• Dec 11, 2023
  DowngradeCitigroup downgrades to Neutral from Buy, price target $95 to $72
• Dec 12, 2022
  UpgradeCitigroup upgrades to Buy from Neutral, price target $90 to $125
• Sep 19, 2022
  InitiateCitigroup starts coverage at Neutral, price target $90

Questions about Citigroup and QDEL

What is Citigroup's price target for QDEL?

Citigroup's latest stated price target for QuidelOrtho Corporation (QDEL) is $33, from its action on Oct 7, 2025.

What is Citigroup's rating on QDEL?

Citigroup rates QDEL Neutral, a neutral rating, as of Oct 7, 2025.

When did Citigroup last change its view on QDEL?

On Oct 7, 2025, Citigroup downgrades to Neutral from Buy, price target $33.

More QDEL rating histories

• Jefferies3
• UBS4
• Raymond James3

All Citigroup ratingsQDEL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.